WSO - April 2023 - 453

1119602
WSO
International Journal of Stroke X(X)Weller et al.
Research
Endovascular thrombectomy in young
patients with stroke
Johannes M Weller1 , Franziska Dorn2, Julius N Meissner1
Sebastian Stösser1 , Niklas M Beckonert1, Julia Nordsiek1
,
,
Christine Kindler1, Milani Deb-Chatterji3 , Gabor C Petzold1
and Felix J Bode1 on behalf of the GSR-ET investigators
Abstract
Background: Endovascular treatment (ET) is standard of care in patients with acute ischemic stroke due to large vessel
occlusion, but data on ET in young patients remain limited.
Aim: We aim to compare outcomes for young stroke patients undergoing ET in a matched cohort.
Methods: We analyzed patients from an observational multicenter cohort with acute ischemic stroke and ET, the
German Stroke Registry-Endovascular Treatment trial. Baseline characteristics, procedural parameters, and functional
outcome at 90 days were compared between young (<50 years) and older (⩾50 years) patients with and without nearest-neighbor
1:1 propensity score matching.
Results: Out of 6628 acute ischemic stroke patients treated with ET, 363 (5.5%) were young. Young patients differed
with regard to prognostic outcome characteristics. Specifically, National Institutes of Health Stroke Scale (NIHSS) at
admission was lower (median 13, interquartile range (IQR) 8-17 vs. 15, IQR 9-19, p < 0.001), and prestroke dependence
was less frequent (2.9% vs. 12.2%, p < 0.001) than in older patients. Compared to a matched cohort of older patients, ET
was faster (time from groin puncture to flow restoration, 35 vs. 45 min, p < 0.001) and intracranial hemorrhage was less
frequent in young patients (10.0% vs. 25.9%, p < 0.001). Good functional outcome (modified Rankin Scale (mRS) 0-2) at
3 months was achieved more frequently in young patients (71.6% vs. 44.1%, p < 0.001), and overall mortality was lower
(6.7% vs. 25.4%, p < 0.001). Among previously employed young patients (n = 177), 37.9% returned to work at 3-month
follow-up, while 74.1% of the remaining patients were still undergoing rehabilitation.
Conclusion: Young stroke patients undergoing ET have better outcomes compared to older patients, even when
matched for prestroke condition, comorbidities, and stroke severity. Hence, more liberal guidelines to perform ET for
younger patients may have to be established by future studies.
Keywords
Stroke, endovascular therapy, mechanical thrombectomy, juvenile stroke, ischemic stroke, large vessel occlusion, clinical
outcome
Received: 8 June 2022; accepted: 25 July 2022
Introduction
Endovascular treatment (ET) is the standard therapy for
patients with acute ischemic stroke (AIS) and large vessel
occlusion (LVO).1-3 Stroke mainly affects elderly patients,
and this is reflected by most ET trials, with a median age
ranging from 68 years in the HERMES trials to 75 years in
clinical registries.1,4 In addition, stroke due to LVO is relatively
rare in young patients, further limiting available data
on ET in this cohort.5 As a result, the benefit of ET in
1 Division of Vascular Neurology, Department of Neurology, University
Hospital Bonn, Bonn, Germany
2 Department of Neuroradiology, University Hospital Bonn, Bonn,
Germany
3 Department of Neurology, University Hospital Hamburg-Eppendorf,
Hamburg, Germany
Corresponding author:
Johannes M Weller, Division of Vascular Neurology, Department of
Neurology, University Hospital Bonn, Venusberg Campus 1, 53127
Bonn, Germany.
Email: Johannes.Weller@ukbonn.de
International Journal of Stroke, 18(4)
International Journal of Stroke
2023, Vol. 18(4) 453 -461
© 2022 World Stroke Organization
Article reuse guidelines:
sagepub.com/journals-permissions
DOI: 10.1177/17474930221119602
journals.sagepub.com/home/wso
https://doi.org/10.1177/17474930221119602
http://www.sagepub.com/journals-permissions https://www.doi.org/10.1177/17474930221119602 http://journals.sagepub.com/home/wso

WSO - April 2023

Table of Contents for the Digital Edition of WSO - April 2023

Contents
WSO - April 2023 - Cover1
WSO - April 2023 - Cover2
WSO - April 2023 - 375
WSO - April 2023 - Contents
WSO - April 2023 - 377
WSO - April 2023 - 378
WSO - April 2023 - 379
WSO - April 2023 - 380
WSO - April 2023 - 381
WSO - April 2023 - 382
WSO - April 2023 - 383
WSO - April 2023 - 384
WSO - April 2023 - 385
WSO - April 2023 - 386
WSO - April 2023 - 387
WSO - April 2023 - 388
WSO - April 2023 - 389
WSO - April 2023 - 390
WSO - April 2023 - 391
WSO - April 2023 - 392
WSO - April 2023 - 393
WSO - April 2023 - 394
WSO - April 2023 - 395
WSO - April 2023 - 396
WSO - April 2023 - 397
WSO - April 2023 - 398
WSO - April 2023 - 399
WSO - April 2023 - 400
WSO - April 2023 - 401
WSO - April 2023 - 402
WSO - April 2023 - 403
WSO - April 2023 - 404
WSO - April 2023 - 405
WSO - April 2023 - 406
WSO - April 2023 - 407
WSO - April 2023 - 408
WSO - April 2023 - 409
WSO - April 2023 - 410
WSO - April 2023 - 411
WSO - April 2023 - 412
WSO - April 2023 - 413
WSO - April 2023 - 414
WSO - April 2023 - 415
WSO - April 2023 - 416
WSO - April 2023 - 417
WSO - April 2023 - 418
WSO - April 2023 - 419
WSO - April 2023 - 420
WSO - April 2023 - 421
WSO - April 2023 - 422
WSO - April 2023 - 423
WSO - April 2023 - 424
WSO - April 2023 - 425
WSO - April 2023 - 426
WSO - April 2023 - 427
WSO - April 2023 - 428
WSO - April 2023 - 429
WSO - April 2023 - 430
WSO - April 2023 - 431
WSO - April 2023 - 432
WSO - April 2023 - 433
WSO - April 2023 - 434
WSO - April 2023 - 435
WSO - April 2023 - 436
WSO - April 2023 - 437
WSO - April 2023 - 438
WSO - April 2023 - 439
WSO - April 2023 - 440
WSO - April 2023 - 441
WSO - April 2023 - 442
WSO - April 2023 - 443
WSO - April 2023 - 444
WSO - April 2023 - 445
WSO - April 2023 - 446
WSO - April 2023 - 447
WSO - April 2023 - 448
WSO - April 2023 - 449
WSO - April 2023 - 450
WSO - April 2023 - 451
WSO - April 2023 - 452
WSO - April 2023 - 453
WSO - April 2023 - 454
WSO - April 2023 - 455
WSO - April 2023 - 456
WSO - April 2023 - 457
WSO - April 2023 - 458
WSO - April 2023 - 459
WSO - April 2023 - 460
WSO - April 2023 - 461
WSO - April 2023 - 462
WSO - April 2023 - 463
WSO - April 2023 - 464
WSO - April 2023 - 465
WSO - April 2023 - 466
WSO - April 2023 - 467
WSO - April 2023 - 468
WSO - April 2023 - 469
WSO - April 2023 - 470
WSO - April 2023 - 471
WSO - April 2023 - 472
WSO - April 2023 - 473
WSO - April 2023 - 474
WSO - April 2023 - 475
WSO - April 2023 - 476
WSO - April 2023 - 477
WSO - April 2023 - 478
WSO - April 2023 - 479
WSO - April 2023 - 480
WSO - April 2023 - 481
WSO - April 2023 - 482
WSO - April 2023 - 483
WSO - April 2023 - 484
WSO - April 2023 - 485
WSO - April 2023 - 486
WSO - April 2023 - 487
WSO - April 2023 - 488
WSO - April 2023 - 489
WSO - April 2023 - 490
WSO - April 2023 - Cover3
WSO - April 2023 - Cover4
https://europe.nxtbook.com/nxteu/sageuk/wso_202404
https://europe.nxtbook.com/nxteu/sageuk/ukstrokeforum_202402_supp
https://europe.nxtbook.com/nxteu/sageuk/wso_202403
https://europe.nxtbook.com/nxteu/sageuk/wso_202402
https://europe.nxtbook.com/nxteu/sageuk/wso_202401
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_US_UKOnly
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_ROW
https://europe.nxtbook.com/nxteu/sageuk/wso_2023101
https://europe.nxtbook.com/nxteu/sageuk/wso_202308
https://europe.nxtbook.com/nxteu/sageuk/wso_202307
https://europe.nxtbook.com/nxteu/sageuk/wso_202306
https://europe.nxtbook.com/nxteu/sageuk/wso_202304
https://europe.nxtbook.com/nxteu/sageuk/wso_202303
https://europe.nxtbook.com/nxteu/sageuk/wso_202302
https://europe.nxtbook.com/nxteu/sageuk/wso_202301
https://www.nxtbookmedia.com